Publications by authors named "J Staub"
Article Synopsis
- This study is a retrospective analysis comparing various metrics (mean work RVUs, operative time, and efficiency measured as wRVUs/min) for single- and multilevel cervical spine fusions conducted from 2011 to 2020.
- The researchers examined data for nearly 101,000 patients, focusing on anterior cervical discectomy and fusion (ACDF) versus posterior cervical decompression and fusion (PCDF), finding that anterior fusions were typically quicker but varied in efficiency depending on the number of fusion levels.
- Results highlighted significant differences between the surgical approaches, indicating that while anterior fusions had lower wRVUs in single and multi-level procedures, they were more efficient in the 1- and 2-level categories
Background And Aims: Lynch syndrome (LS) is caused by pathogenic mutations in mismatch repair (MMR) genes. There are limited data on differences in colorectal cancer (CRC) surveillance by MMR genes, and an international consensus on surveillance based on genes is not established. We aimed to evaluate colonoscopy and esophagogastroduodenoscopy (EGD) surveillance outcomes and compare CRC surveillance findings by the mutated gene.
View Article and Find Full Text PDFArticle Synopsis
- This study is a Level 3 retrospective database investigation focusing on trends in various RVUs (work, practice expense, and malpractice) and MS-DRG reimbursements for cervical spine fusion surgeries from 2011 to 2023, particularly during the COVID-19 pandemic.
- The analysis showed no changes in work RVUs, while practice expense RVUs experienced a slight decline and malpractice RVUs saw a modest increase; all facility prices for the procedures decreased when adjusted for inflation.
- The research findings indicated that, despite stable RVU reimbursement, there were slight variations in MS-DRG metrics like length of stay, with different yearly percent changes for each code, highlighting complexities in reimbursement trends for cervical spine fusions.
Background: Hemorrhagic strokes constitute 10-15% of all strokes and have the worst mortality and morbidity of all subtypes. Mortality and morbidity of spontaneous intracerebral hemorrhage (sICH) are often secondary to the effects of inflammation, brain edema, and swelling. Studies have shown that celecoxib, a selective cyclooxygenase 2 (COX-2) inhibitor, reduces perihematomal edema formation and inflammation.
View Article and Find Full Text PDF